All stock lists
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
29.42+0.66 (+2.29%)
Insider Score
––Not scored
KMTS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KMTS Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 31, 2026 | Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 |
| Revenue | 30.97 M | 28.64 M | 24.55 M | 22.57 M | 19.37 M | 17.23 M |
| Revenue Growth (YoY) | 59.88 % | 66.18 % | 62.70 % | 53.40 % | 51.55 % | 71.40 % |
| Cost of Revenue | 13.47 M | 12.96 M | 11.65 M | 11.14 M | 10.52 M | 9.60 M |
| Gross Profit | 17.50 M | 15.68 M | 12.91 M | 11.42 M | 8.85 M | 7.63 M |
| SG&A Expense | 48.36 M | 49.39 M | 42.70 M | 38.30 M | 33.73 M | 50.46 M |
| R&D Expense | 6.80 M | 5.63 M | 4.97 M | 4.88 M | 4.00 M | 5.39 M |
| Operating Expenses | 55.16 M | 55.03 M | 47.67 M | 43.18 M | 37.73 M | 55.84 M |
| Operating Income | -37.66 M | -39.34 M | -34.76 M | -31.75 M | -28.88 M | -48.21 M |
| Pretax Income | -44.04 M | -38.64 M | -34.13 M | -32.75 M | -25.79 M | -51.01 M |
| Tax Provision | 50.00 K | 192.00 K | 35.00 K | 34.00 K | 33.00 K | 102.00 K |
| Net Income | -44.09 M | -38.84 M | -34.17 M | -32.78 M | -25.83 M | -52.05 M |
| EPS (Basic) | -0.75 | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 |
| EPS (Diluted) | -0.75 | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 |
| Shares Outstanding | 58.57 M | 58.40 M | 52.84 M | 51.38 M | 51.30 M | 49.53 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.